<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               <BR>                  ADVERSE REACTIONS<BR><BR>               <BR>               <BR>                  Table 2 reports the incidence rate of treatment-emergent adverse events over five days of tramadol hydrochloride and acetaminophen tablets use in clinical trials (subjects took an average of at least 6 tablets per day).<BR>                  <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" frame="void" width="650"><BR>                     <thead><BR>                        <tr><BR>                           <td styleCode="BotruleToprule" align="center" valign="top" colspan="2"><BR>                              <content styleCode="bold">Table 2: Incidence of Treatment-Emergent Adverse Events (&#8805;2.0%)</content><BR>                           </td><BR>                        </tr><BR>                        <tr><BR>                           <td styleCode="BotruleToprule" align="center" valign="top"><BR>                              <content styleCode="bold">Body System</content><BR>                              <content styleCode="bold"><BR>                                 <br/><BR>                              </content><BR>                              <content styleCode="bold">Preferred Term</content><BR>                           </td><BR>                           <td styleCode="BotruleToprule" align="center" valign="top"><BR>                              <content styleCode="bold">Tramadol Hydrochloride and</content><BR>                              <content styleCode="bold"><BR>                                 <br/><BR>                              </content><BR>                              <content styleCode="bold">Acetaminophen Tablets</content><BR>                              <content styleCode="bold"><BR>                                 <br/><BR>                              </content><BR>                              <content styleCode="bold">(N=142)</content><BR>                              <content styleCode="bold"><BR>                                 <br/><BR>                              </content>%</td><BR>                        </tr><BR>                     </thead><BR>                     <tbody><BR>                        <tr><BR>                           <td styleCode="Toprule" valign="top"><BR>                              <content styleCode="bold">Gastrointestinal System Disorders</content><BR>                           </td><BR>                           <td styleCode="Toprule" valign="top"/><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top">Constipation</td><BR>                           <td align="center" valign="top">6</td><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top">Nausea</td><BR>                           <td align="center" valign="top">3</td><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top">Diarrhea</td><BR>                           <td align="center" valign="top">3</td><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top">Dry Mouth</td><BR>                           <td align="center" valign="top">2</td><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top"><BR>                              <content styleCode="bold">Psychiatric Disorders</content><BR>                           </td><BR>                           <td align="center" valign="top"/><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top">Somnolence</td><BR>                           <td align="center" valign="top">6</td><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top">Anorexia</td><BR>                           <td align="center" valign="top">3</td><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top">Insomnia</td><BR>                           <td align="center" valign="top">2</td><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top"><BR>                              <content styleCode="bold">Central &amp; Peripheral Nervous System</content><BR>                           </td><BR>                           <td align="center" valign="top"/><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top">Dizziness</td><BR>                           <td align="center" valign="top">3</td><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top"><BR>                              <content styleCode="bold">Skin and Appendages</content><BR>                           </td><BR>                           <td align="center" valign="top"/><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top">Sweating Increased</td><BR>                           <td align="center" valign="top">4</td><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top">Pruritus</td><BR>                           <td align="center" valign="top">2</td><BR>                        </tr><BR>                        <tr><BR>                           <td valign="top"><BR>                              <content styleCode="bold">Reproductive Disorders, Male *</content><BR>                           </td><BR>                           <td align="center" valign="top"/><BR>                        </tr><BR>                        <tr><BR>                           <td styleCode="Botrule" valign="top">Prostatic Disorder</td><BR>                           <td styleCode="Botrule" align="center" valign="top">2</td><BR>                        </tr><BR>                     </tbody><BR>                  </table><BR>                  <BR><BR><BR><BR>                     <BR>                        <BR>                        <BR>                           <BR>                              *<BR>                            Number of males = 62<BR>                     <BR>                  <BR>                  <BR>                     Incidence at least 1%, causal relationship at least possible or greater: the following lists adverse reactions that occurred with an incidence of at least 1% in single-dose or repeated-dose clinical trials of tramadol hydrochloride and acetaminophen tablets.<BR>                  <BR>                     Body as a Whole – Asthenia, fatigue, hot flushes<BR>                  <BR>                     Central and Peripheral Nervous System – Dizziness, headache, tremor<BR>                  <BR>                     Gastrointestinal System – Abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting<BR>                  <BR>                     Psychiatric Disorders – Anorexia, anxiety, confusion, euphoria, insomnia, nervousness, somnolence<BR>                  <BR>                     Skin and Appendages – Pruritus, rash, increased sweating.<BR>                  <BR>                     Selected Adverse events occurring at less than 1%: the following lists clinically relevant adverse reactions that occurred with an incidence of less than 1% in tramadol hydrochloride and acetaminophen tablets clinical trials.<BR>                  <BR>                     Body as a Whole – Chest pain, rigors, syncope, withdrawal syndrome<BR>                  <BR>                     Cardiovascular Disorders – Hypertension, aggravated hypertension, hypotension<BR>                  <BR>                     Central and Peripheral Nervous System – Ataxia, convulsions, hypertonia, migraine, aggravated migraine, involuntary muscle contractions, paresthesias, stupor, vertigo<BR>                  <BR>                     Gastrointestinal System – Dysphagia, melena, tongue edema<BR>                  <BR>                     Hearing and Vestibular Disorders – Tinnitus Heart Rate and Rhythm Disorders – Arrhythmia, palpitation, tachycardia<BR>                  <BR>                     Liver and Biliary System – Hepatic function abnormal<BR>                  <BR>                     Metabolic and Nutritional Disorders – Weight decrease<BR>                  <BR>                     Psychiatric Disorders – Amnesia, depersonalization, depression, drug abuse, emotional lability, hallucination, impotence, paroniria, abnormal thinking<BR>                  <BR>                     Red Blood Cell Disorders – Anemia<BR>                  <BR>                     Respiratory System – Dyspnea<BR>                  <BR>                     Urinary System – Albuminuria, micturition disorder, oliguria, urinary retention<BR>                  <BR>                     Vision Disorders – Abnormal vision<BR>                  <BR>                     Other clinically significant adverse experiences previously reported with tramadol hydrochloride. <BR>                  <BR>                  Other events which have been reported with the use of tramadol products and for which a causal association has not been determined include: vasodilation, orthostatic hypotension, myocardial ischemia, pulmonary edema, allergic reactions (including anaphylaxis and urticaria, Stevens-Johnson syndrome/TENS), cognitive dysfunction, difficulty concentrating, depression, suicidal tendency, hepatitis liver failure and gastrointestinal bleeding. Reported laboratory abnormalities included elevated creatinine and liver function tests. Serotonin syndrome (whose symptoms may include mental status change, hyperreflexia, fever, shivering, tremor, agitation, diaphoresis, seizures and coma) has been reported with tramadol when used concomitantly with other serotonergic agents such as SSRIs and MAOIs.<BR>                  <BR>                     Other clinically significant adverse experiences previously reported with acetaminophen. <BR>                  <BR>                  Allergic reactions (primarily skin rash) or reports of hypersensitivity secondary to acetaminophen are rare and generally controlled by discontinuation of the drug and, when necessary, symptomatic treatment.<BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>